HomeCompareRDUS vs JNJ

RDUS vs JNJ: Dividend Comparison 2026

RDUS yields 2.50% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.8K in total portfolio value· pulled ahead in Year 8
10 years
RDUS
RDUS
● Live price
2.50%
Share price
$30.00
Annual div
$0.75
5Y div CAGR
1.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.7K
Annual income
$334.00
Full RDUS calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — RDUS vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDUSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDUS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDUS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDUS
Annual income on $10K today (after 15% tax)
$212.50/yr
After 10yr DRIP, annual income (after tax)
$283.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,753.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDUS + JNJ for your $10,000?

RDUS: 50%JNJ: 50%
100% JNJ50/50100% RDUS
Portfolio after 10yr
$27.1K
Annual income
$2,541.94/yr
Blended yield
9.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RDUS
Analyst Ratings
8
Buy
13
Hold
2
Sell
Consensus: Hold
Altman Z
3.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDUS buys
0
JNJ buys
0
No recent congressional trades found for RDUS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDUSJNJ
Forward yield2.50%2.14%
Annual dividend / share$0.75$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR1.2%28%
Portfolio after 10y$23.7K$30.5K
Annual income after 10y$334.00$4,749.88
Total dividends collected$2.9K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: RDUS vs JNJ ($10,000, DRIP)

YearRDUS PortfolioRDUS Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,953$253.00$10,594$274.49+$359.00RDUS
2$11,982$262.09$11,294$360.69+$688.00RDUS
3$13,092$271.17$12,133$476.91+$959.00RDUS
4$14,288$280.22$13,156$635.42+$1.1KRDUS
5$15,578$289.26$14,432$854.61+$1.1KRDUS
6$16,966$298.27$16,056$1,162.76+$910.00RDUS
7$18,461$307.25$18,175$1,604.53+$286.00RDUS
8← crossover$20,070$316.20$21,009$2,252.68$939.00JNJ
9$21,800$325.12$24,911$3,229.73$3.1KJNJ
10$23,660$334.00$30,458$4,749.88$6.8KJNJ

RDUS vs JNJ: Complete Analysis 2026

RDUSStock

Radius Recycling, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel, brass, titanium, lead, and high temperature alloys. The company also procures salvaged vehicles and sells serviceable used auto parts from these vehicles. In addition, it produces various finished steel products using ferrous recycled metal and other raw materials, as well as semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. Further, the company sells catalytic converters to specialty processors that extract the nonferrous precious metals, including platinum, palladium, and rhodium; and ferrous and nonferrous recycled metal products to steel mills, foundries, refineries, smelters, wholesalers, and recycled metal processors, as well as finished steel customers, such as steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and major farm and wood products suppliers. It also provides recycling and related services, including scrap brokerage, certified destruction, automotive parts recycling, railcar dismantling, and reverse logistics under 3PR brand name. The company was formerly known as Schnitzer Steel Industries, Inc. and changed its name to Radius Recycling, Inc. in January 2024. Radius Recycling, Inc. was founded in 1906 and is headquartered in Portland, Oregon.

Full RDUS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RDUS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDUS vs SCHDRDUS vs JEPIRDUS vs ORDUS vs KORDUS vs MAINRDUS vs ABBVRDUS vs MRKRDUS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.